SVA [SINOVAC BIOTECH] F-3: Law Debenture Corporate Services Inc. Copies to: st

[Law Debenture Corporate Services Inc. Copies to: st David T. Zhang, Esq. Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement. o ý o o o o CALCULATION OF REGISTRATION FEE] [[Letterhead of Rhudd & Associates] November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Sirs, Sinovac Biotech Ltd. (the “Company”) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the “Prospectus”) contained] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road Haidian District, Beijing 100085 People’s Republic of China Ladies and Gentlemen: Company Securities Registration Statement We have acted as special U.S. counsel to Sinovac Biotech Ltd., a limited liability corporation incorporated in Antigua, West Indies (the “ The facts, as we understand them, and upon which with your permission we] [November 18, 2009 Sinovac Biotech Ltd. No.39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Sirs, Sinovac Biotech Ltd. (the “Company”) For the purposes of giving this opinion, we have examined and relied upon copies of the following draft documents: (i) the Registration Statement; and (ii) the prospectus (the “Prospectus”) contained in the Registration Statement. We] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Vancouver, Canada, November 18, 2009 Chartered Accountants]

By | 2016-03-24T04:03:30+00:00 November 18th, 2009|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[SINOVAC BIOTECH LTD. CONSOLIDATED FINANCIAL STATEMENTS (Expressed in U.S. Dollars) (Unaudited) September 30 , 2009 Index Consolidated Balance Sheets Consolidated Statement of Changes in Stockholders’ Equity Consolidated Statements of Income and Comprehensive Income Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements SINOVAC BIOTECH LTD. Consolidated Balance Sheets (Unaudited) (Expressed in U.S. Dollars) September 30, December 31, 2009 2008] [1 -32371 SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o Submission of Financial Statements We are including in this Current Report on Form 6-K our unaudited consolidated financial statements for the three months and nine months ended September 30, 2008 and 2009 and as of]

By | 2016-03-24T04:04:33+00:00 November 18th, 2009|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: SINOVAC BIOTECH LTD. CONSOLIDATED FINANCIAL STATEMENTS (Expressed in

[SINOVAC BIOTECH LTD. CONSOLIDATED FINANCIAL STATEMENTS (Expressed in U.S. Dollars) (Unaudited) September 30 , 2009 Index Consolidated Balance Sheets Consolidated Statement of Changes in Stockholders’ Equity Consolidated Statements of Income and Comprehensive Income Consolidated Statements of Cash Flows Notes to Consolidated Financial Statements SINOVAC BIOTECH LTD. Consolidated Balance Sheets (Unaudited) (Expressed in U.S. Dollars) September 30, December 31, 2009 2008] [1 -32371 SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o Submission of Financial Statements We are including in this Current Report on Form 6-K our unaudited consolidated financial statements for the three months and nine months ended September 30, 2008 and 2009 and as of]

By | 2016-03-24T04:05:37+00:00 November 18th, 2009|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[It is anticipated that Sinovac's common shares will commence trading on NASDAQ on or about November 16, 2009. Sinovac will continue to trade under the ticker symbol "SVA." Mr. Weidong Yin, Chairman, President and CEO of Sinovac, stated, "The transfer of our stock listing to NASDAQ demonstrates our continued focus on creating shareholder value. We appreciate the support that the] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]

By | 2016-03-24T04:16:24+00:00 November 4th, 2009|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Skip to toolbar